Vanta Bioscience Ltd.
Snapshot View

73.85 ▼0%

16 November 2022, 04:01:00 PM

Overview View Details >>

Sector Miscellaneous Compare with Sector peers
Industry Miscellaneous Compare with Industry peers
Website http://www.vantabio.com
Market Cap 46.61 Cr.
Enterprise Value(EV) 79.93 Cr. 2021-03
Financial Indicators
Earnings per share (EPS) 0.14 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 529.71 Trailing Twelve Months Ending 2022-03
Industry PE 18.50 Trailing Twelve Months Ending 2022-03
Book Value / Share 37.89 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.95 Calculated using Price: 73.85
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.63 Cr. 6,312,000 Shares
FaceValue 10
Company Profile
The company is a preclinical contract research organization, offering a host of preclinical safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries. In addition they also provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBS also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers. Their services include toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
1 Month
-0.20%
3 Month
-12.08%
6 Month
-32.83%
1 Year
-30.26%
2 Year
-48.72%
5 Year
+35.50%
10 Year
3 years 2019-03 2020-03 2021-03
Return on Equity (%) 3.14 4.43 1.89
Return on Capital Employed (%) 7.87 8.62 5.42
Return on Assets (%) 1.78 2.31 0.76

Balance Sheet View Details >>

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Shh. Funds 22 23 24
Non Curr. Liab. 13 14 29
Curr. Liab. 3 10 15
Minority Int. 1 1 2
Equity & Liab. 39 49 70
Non Curr. Assets 22 29 50
Curr. Assets 17 20 20
Misc. Exp. not W/O
Total Assets 39 49 70

Profit Loss View Details >>

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Net Sales 12 14 10
Other Income 0 0 0
Total Income 12 14 10
Total Expenditure -9 -9 -6
PBIDT 4 4 4
Interest -2 -2 -2
Depreciation -1 -1 -1
Taxation 0 0 0
Exceptional Items
PAT 1 1 0
Minority Interest 0
Share Associate
Other Related Items
Consolidated Net Profit 1 1 0
Adjusted EPS 1 2 1

Cash Flow View Details >>

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. -1 2 7
Cash Fr. Inv. -6 -7 -22
Cash Fr. Finan. 10 2 18
Net Change 3 -3 2
Cash & Cash Eqvt 3 0 3

Shareholding Pattern View Details >>

9 Qtrs 2018-09 (%) 2019-03 (%) 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2022-03 (%) 2022-09 (%)
Promoter 72.45 69.93 69.93 69.93 69.93 69.11 69.00 69.00 69.36
Public 27.55 30.07 30.07 30.07 30.07 30.89 31.00 31.00 30.64
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 24 Nov 2022
Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Updates regarding hearing on November 09 2022 and November 18 2022
Mon, 14 Nov 2022
Results-Delay in Financial Results
Delay in submission of financial results for the half year ended 30.09.2022
Tue, 08 Nov 2022
Board Meeting Intimation for Approval Of Unaudited Financials (Standalone & Consolidation) For The Half Year Ended 30.09.2022
Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2022 inter alia to consider and approve unaudited financials (standalone & consolidation) for the half year ended 30.09.2022

Technical Scans View Details >>

No Scans Found

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Latent View Analytics Ltd. 7,655.11 376.25 +0.2%
RattanIndia Enterprises Ltd. 6,745.48 48.80 +0.3%
SIS Ltd. 5,683.59 389.25 0.0%
TeamLease Services Ltd. 4,252.56 2,486.95 -1.9%
EKI Energy Services Ltd. 3,927.09 1,427.90 +0.3%
Dreamfolks Services Ltd. 1,941.61 371.15 -1.2%
VA Tech Wabag Ltd. 1,933.81 311.00 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Latent View Analytics Ltd. Consolidated 2022-09 49.55 376.25 +0.2%
RattanIndia Enterprises Ltd. Consolidated 2022-09 15.10 48.80 +0.3%
SIS Ltd. Consolidated 2022-09 16.33 389.25 0.0%
TeamLease Services Ltd. Consolidated 2022-09 35.40 2,486.95 -1.9%
EKI Energy Services Ltd. Consolidated 2022-03 10.25 1,427.90 +0.3%
Dreamfolks Services Ltd. Consolidated 2022-03 119.60 371.15 -1.2%
VA Tech Wabag Ltd. Consolidated 2022-09 11.56 311.00 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Latent View Analytics Ltd. Consolidated 2022-09 6.89 376.25 +0.2%
RattanIndia Enterprises Ltd. Consolidated 2022-09 11.51 48.80 +0.3%
SIS Ltd. Consolidated 2022-09 2.71 389.25 0.0%
TeamLease Services Ltd. Consolidated 2022-09 5.60 2,486.95 -1.9%
EKI Energy Services Ltd. Consolidated 2022-03 6.34 1,427.90 +0.3%
Dreamfolks Services Ltd. Consolidated 2022-03 17.40 371.15 -1.2%
VA Tech Wabag Ltd. Consolidated 2022-09 1.20 311.00 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Latent View Analytics Ltd. Consolidated 2022-03 0.00 376.25 +0.2%
RattanIndia Enterprises Ltd. Consolidated 2022-03 0.17 48.80 +0.3%
SIS Ltd. Consolidated 2022-03 0.65 389.25 0.0%
TeamLease Services Ltd. Consolidated 2022-03 0.04 2,486.95 -1.9%
EKI Energy Services Ltd. Consolidated 2022-03 0.00 1,427.90 +0.3%
Dreamfolks Services Ltd. Consolidated 2022-03 0.02 371.15 -1.2%
VA Tech Wabag Ltd. Consolidated 2022-03 0.28 311.00 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Latent View Analytics Ltd. Consolidated 2022-03 17.75 376.25 +0.2%
RattanIndia Enterprises Ltd. Consolidated 2022-03 141.37 48.80 +0.3%
SIS Ltd. Consolidated 2022-03 16.70 389.25 0.0%
TeamLease Services Ltd. Consolidated 2022-03 5.89 2,486.95 -1.9%
EKI Energy Services Ltd. Consolidated 2022-03 93.56 1,427.90 +0.3%
Dreamfolks Services Ltd. Consolidated 2022-03 22.39 371.15 -1.2%
VA Tech Wabag Ltd. Consolidated 2022-03 9.17 311.00 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Latent View Analytics Ltd. Consolidated 2022-03 17.75 376.25 +0.2%
RattanIndia Enterprises Ltd. Consolidated 2022-03 141.37 48.80 +0.3%
SIS Ltd. Consolidated 2022-03 16.70 389.25 0.0%
TeamLease Services Ltd. Consolidated 2022-03 5.89 2,486.95 -1.9%
EKI Energy Services Ltd. Consolidated 2022-03 93.56 1,427.90 +0.3%
Dreamfolks Services Ltd. Consolidated 2022-03 22.39 371.15 -1.2%
VA Tech Wabag Ltd. Consolidated 2022-03 9.17 311.00 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Latent View Analytics Ltd. Consolidated 2022-03 407.82 376.25 +0.2%
RattanIndia Enterprises Ltd. Consolidated 2022-03 13.99 48.80 +0.3%
SIS Ltd. Consolidated 2022-03 10,059.08 389.25 0.0%
TeamLease Services Ltd. Consolidated 2022-03 6,479.82 2,486.95 -1.9%
EKI Energy Services Ltd. Consolidated 2022-03 1,800.12 1,427.90 +0.3%
Dreamfolks Services Ltd. Consolidated 2022-03 282.50 371.15 -1.2%
VA Tech Wabag Ltd. Consolidated 2022-03 2,979.30 311.00 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Latent View Analytics Ltd. Consolidated 2022-03 129.51 376.25 +0.2%
RattanIndia Enterprises Ltd. Consolidated 2022-03 553.86 48.80 +0.3%
SIS Ltd. Consolidated 2022-03 323.33 389.25 0.0%
TeamLease Services Ltd. Consolidated 2022-03 39.45 2,486.95 -1.9%
EKI Energy Services Ltd. Consolidated 2022-03 383.04 1,427.90 +0.3%
Dreamfolks Services Ltd. Consolidated 2022-03 16.25 371.15 -1.2%
VA Tech Wabag Ltd. Consolidated 2022-03 135.22 311.00 -0.3%

FAQ's On Vanta Bioscience Ltd.

What is Vanta Bioscience share price?

Can I buy Vanta Bioscience shares now?

What is the Market Cap of Vanta Bioscience?

What are the key metrics to analyse Vanta Bioscience?

What is the 52 Week High and Low of Vanta Bioscience?